Aveanna Healthcare Holdings Inc.
NASDAQ:AVAHMedical - Care Facilities
+$0.10 today
- Market cap
- $2.37B
- Beta
- 1.93
- P/E (TTM)
- 6.3
- EPS (TTM)
- $1.22
Volume 2.12M
Average 1.52M
AVAH Financing Cash Flow
Net cash exchanged with lenders and shareholders through borrowing, repayments, buybacks, and dividends.
Aveanna Healthcare Holdings Inc.NASDAQ: AVAH
Financing Cash Flow · Q3 FY2026 · quarter ended Oct 2026
Financing cash flow grows, but more slowly than its trailing trend
Q3 FY2026 financing cash flow of $37.16M rose 166.4% year over year, behind the +13650.2% change in trailing-twelve-month financing cash flow. Sequentially, it rose 1473.9% from the prior quarter. Over 3 fiscal years it compounded at -55.7% a year.
Context
- Financing cash flow amounted to 0.2% of revenue in FY2025, down 0.5 pp from a year earlier.
- Financing cash flow increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from +166.4% toward the trailing-twelve-month pace of +13650.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Financing Cash Flow history
USD · from the cash flow
- Latest · FY2025
- 5.41M USD
- Year-over-year change
- -61.4%
- 4-year CAGR
- -69.0%
| Period | Period end | Financing Cash Flow | YoY change |
|---|---|---|---|
| FY2025 | 2026-01-03 | 5.41M | -61.4% |
| FY2024 | 2024-12-28 | 14.03M | +29.3% |
| FY2023 | 2023-12-30 | 10.85M | -82.6% |
| FY2022 | 2022-12-31 | 62.42M | -89.4% |
| FY2021 | 2022-01-01 | 586.33M | — |
Financing Cash Flow vs competitors
How AVAH compares with its peers on the latest reported figures
- AVAH's LTM Oct 2026 financing cash flow of $35.37M is the 6th largest of the 7 companies compared; the peer median is $198.75M.
- Its year-over-year change of +13650.2% is the highest of 7, against a peer median of +24.2%.
- Financing cash flow amounts to 1.3% of revenue for AVAH, versus a peer median of 6.7%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | $503.42M | +48.2% | +27.4% | 19.4% | |
| LTM Jun 2026 | $391.8M | -15.0% | +43.8% | 6.3% | |
| LTM Sep 2026 | $291.5M | +6.7% | — | 5.1% | |
| LTM Mar 2026 | $116.62M | +41.7% | +142.6% | 11.4% | |
| LTM Jun 2026 | $106M | -161.1% | +3.3% | 7.2% | |
| LTM Oct 2026 | $35.37M | +13650.2% | -55.7% | 1.3% | |
| LTM Mar 2026 | $10.41M | +156.8% | -27.6% | 3.6% | |
| Peer median (excluding AVAH) | $198.75M | +24.2% | +27.4% | 6.7% | |
Competitors are the stored peer set for AVAH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Jan 2022 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Jan 2026 |
|---|---|---|---|---|---|
| Net Income | (117.04M) | (662.03M) | (134.52M) | (10.93M) | 225.03M |
| Depreciation & Amortization | 35.39M | 38.82M | 30.1M | 31.16M | 28.22M |
| Deferred Income Tax | 1.31M | (115K) | 1.02M | 1.04M | (143.03M) |
| Stock-Based Compensation | 14.43M | 15.89M | 13.16M | 17.47M | 0 |
| Change in Working Capital | (71.33M) | (42.22M) | (23.4M) | (29.97M) | (52.66M) |
| Accounts Receivables | (8.81M) | (3.23M) | (15.32M) | (28.64M) | (30.22M) |
| Inventory | (27.06M) | 0 | 0 | 0 | 0 |
| Accounts Payables | (11.7M) | (3.93M) | (13.92M) | 6.45M | (6.23M) |
| Other Working Capital | (23.76M) | (35.07M) | 5.85M | (7.78M) | (16.21M) |
| Other Non-Cash Items | 125.9M | 601.26M | 136.32M | 23.87M | 68.29M |
| Operating Cash Flow | (11.35M) | (48.4M) | 22.67M | 32.64M | 125.86M |
| Capital Expenditures | (15.95M) | (12.01M) | (6.12M) | (6.32M) | (7.45M) |
| Acquisitions (Net) | (666.92M) | (1.55M) | 0 | 0 | (14.85M) |
| Purchases of Investments | (853K) | (11.73M) | 0 | 0 | 0 |
| Sales of Investments | 1.89M | 11.27M | 0 | 0 | 0 |
| Other Investing Activities | 0 | (11.27M) | (2.68M) | 0 | 0 |
| Investing Cash Flow | (681.83M) | (25.29M) | (8.79M) | (6.32M) | (22.3M) |
| Debt Repayment | 161.59M | 60.15M | (5.73M) | (2.36M) | (3.76M) |
| Common Stock Issued | 477.69M | 4.02M | 945K | 3.09M | 6.52M |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (52.95M) | (1.74M) | 15.63M | 13.3M | 2.65M |
| Financing Cash Flow | 586.33M | 62.42M | 10.85M | 14.03M | 5.41M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | (106.86M) | (11.27M) | 24.73M | 40.35M | 108.97M |
| Free Cash Flow | (27.3M) | (60.42M) | 16.56M | 26.32M | 118.41M |
Aveanna Healthcare Holdings Inc.
NASDAQ:AVAH
Intrinsic Alpha fair value
Locked
Current Price
$10.85
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.